AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 26-50/53
Prevalence of hypertension in a Mexican population according to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluationand Treatment of High Blood Pressure
Authors: Gonzalez-Villalpando, C Stern, MP Haffner, SM Villapando, MEG Gaskill, S Martinez, DR
Citation: C. Gonzalez-villalpando et al., Prevalence of hypertension in a Mexican population according to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluationand Treatment of High Blood Pressure, J CARD RISK, 6(3), 1999, pp. 177-181
LDL size in African Americans, Hispanics, and non-Hispanic whites - The insulin resistance atherosclerosis study
Authors: Haffner, SM D'Agostino, R Goff, D Howard, B Festa, A Saad, MF Mykkanen, L
Citation: Sm. Haffner et al., LDL size in African Americans, Hispanics, and non-Hispanic whites - The insulin resistance atherosclerosis study, ART THROM V, 19(9), 1999, pp. 2234-2240
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance - The Insulin Resistance Atherosclerosis Study (IRAS)
Authors: Festa, A D'Agostino, R Mykkanen, L Tracy, RP Zaccaro, DJ Hales, CN Haffner, SM
Citation: A. Festa et al., Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance - The Insulin Resistance Atherosclerosis Study (IRAS), ART THROM V, 19(3), 1999, pp. 562-568
Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels - The Insulin Resistance Atherosclerosis Study
Authors: Festa, A D'Agostino, R Mykkanen, L Tracy, R Howard, BV Haffner, SM
Citation: A. Festa et al., Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels - The Insulin Resistance Atherosclerosis Study, ART THROM V, 19(3), 1999, pp. 605-610
LDL size and risk of coronary heart disease in elderly men and women
Authors: Mykkanen, L Kuusisto, J Haffner, SM Laakso, M Austin, MA
Citation: L. Mykkanen et al., LDL size and risk of coronary heart disease in elderly men and women, ART THROM V, 19(11), 1999, pp. 2742-2748
Is leptin concentration associated with the insulin resistance syndrome innondiabetic men?
Authors: Haffner, SM Mykkanen, L Rainwater, DL Karhapaa, P Laakso, M
Citation: Sm. Haffner et al., Is leptin concentration associated with the insulin resistance syndrome innondiabetic men?, OBES RES, 7(2), 1999, pp. 164-169
Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus
Authors: Festa, A Shnawa, N Schernthaner, G Haffner, SM
Citation: A. Festa et al., Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus, EXP CL E D, 107(7), 1999, pp. 447-452
Evaluating the status of diabetes as a risk factor for coronary artery disease
Authors: Haffner, SM
Citation: Sm. Haffner, Evaluating the status of diabetes as a risk factor for coronary artery disease, ACT DIABETO, 36(3), 1999, pp. S30-S34
Relative hypoleptinaemia in women with mild gestational diabetes mellitus
Authors: Festa, A Shnawa, N Krugluger, W Hopmeier, P Schernthaner, G Haffner, SM
Citation: A. Festa et al., Relative hypoleptinaemia in women with mild gestational diabetes mellitus, DIABET MED, 16(8), 1999, pp. 656-662
Relationship of low-density lipoprotein particle size and measures of adiposity
Authors: Rainwater, DL Mitchell, BD Comuzzie, AG Haffner, SM
Citation: Dl. Rainwater et al., Relationship of low-density lipoprotein particle size and measures of adiposity, INT J OBES, 23(2), 1999, pp. 180-189
Metabolic predictors of hypertension
Authors: Haffner, SM
Citation: Sm. Haffner, Metabolic predictors of hypertension, J HYPERTENS, 17, 1999, pp. S23-S28
Insulin sensitivity in subjects with type 2 diabetes - Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study
Authors: Haffner, SM D'Agostino, R Mykkanen, L Tracy, R Howard, B Rewers, M Selby, J Savage, PJ Saad, MF
Citation: Sm. Haffner et al., Insulin sensitivity in subjects with type 2 diabetes - Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study, DIABET CARE, 22(4), 1999, pp. 562-568
The Diabetes Prevention Program - Design and methods for a clinical trial in the prevention of type 2 diabetes
Authors: Bray, GA Culbert, IW Champagne, CM Dawson, L Eberhardt, B Greenway, FL Guillory, FG Hebert, AA Jeffirs, ML Kennedy, BM Lovejoy, JC Morris, LH Melancon, LE Reed, L Perault, J Ryan, DH Sanford, DA Smith, KG Smith, LL St Amant, JA Tulley, RT Vicknair, PC Williamson, D Zachwieja, JJ Polonsky, KS Matulik, MJ Clarke, B DeSandre, C Ehrmann, DA Hilbrich, RM McNabb, WL Morrone, D Semenske, AR Stepp, KA Tobian, JA Watson, PG Caro, JF Goldstein, BJ Graziani, CM Kunkel, EJ Laine, CA Louis, DZ Smith, KA Spandirfer, J Yuen, EJ Goldberg, RB Rowe, P Calles, J Donahue, RP Florez, HJ Giannella, A O'Hara, P Prineas, R Haffner, SM Montez, MG Miettinen, H Mobley, CM Mykkanen, LA Hamman, RF Nash, PV Calonge, BN Hill, JO Jortberg, BT Regensteiner, JG Reusch, J Schiltz, CM Seagle, H VanDorsten, B Horton, ES Lawton, KE Arky, RA Bryant, M Burke, JP Caballero, E Callaphan, KM Ganda, OP Franklin, T Jackson, SD Jacobsen, AM Kula, LM Kocal, M Malloy, MA Nicosia, M Oldmixon, CF Pan, J Quitingon, M Rubtchinsky, S Seely, EW Schweizer, D Simonson, D Smith, F Solomon, CG Warram, J Kahn, SE Montgomery, BK Berger, M Boyko, EJ Fujimoto, WY Greenbaum, CJ Knopp, RH McCann, BS Lipkin, EW Nguyen, TT Palmer, JP Schwartz, RS Talbot-Lawson, C Wan, D Kitabchi, AE Murphy, ME Applegate, WB Bryer-Ash, M Frieson, SL Imseis, R Kennedy, CL Lambeth, HC Lichtermann, LC Oktaei, H O'Toole, ML Rutledge, LMK Sherman, AR Smith, CM Soberman, JE Williams-Cleaves, BJ Metzger, BE Johnson, MK Fitzgibbon, M Heard, D Johnson, CKH McPherson, D Molitch, ME Moore, M Pitts, T Schinleber, PA Nathan, DM McKitrick, C Abbott, K Anderson, E Cagliero, E Cohen, M Crowell, S Delahanty, L Levina, E Michel, T O'Keefe, J Poulos, A Ronan, L Rosal, M Salerno, M Shagensky, C Steiner, B Young, A Olefsky, JM Carrion-Petersen, ML Barrett-Connor, E Beltran, M Caenepeel, K Edelman, SV Ford, RO Garcia, J Henry, RR Hill, M Horne, J Leos, D Mudaliar, S Pollard, A Torio, J Pi-Sunyer, FX Lee, JE Allison, DB Aronoff, NJ Barreras, IM Crandall, JP Foo, ST Orlando, SJ Parkes, K Rooney, ES Van Wye, GEH Viscovich, KA Prince, MJ Kukman, SM Dotson, YF Fineberg, ES Guare, JC Ignaut, JM Jackson, MA Kirkman, MS Marrero, DG Porter, DB Rowland, ND Wheeler, ML Ratner, RE Youssef, G Bronsord, M Cheatham, WW Boggs, G Evans, C Levatan, C Kellum, T Nair, AK Passaro, MD Saad, MF Khan, A Aziz, A Bernaba, B Budgett, MD Cosenza, C Hagar, JE Isagholian, K Jinagouda, SD Kamdar, VV Kumar, D Khawaja, Q Kelada, BL Lui, G Marston, AR Mehta, V Sharma, AR Szamos, K Vargas, A Vargas, B Zambrana, N Dagogo-Jack, S Santiago, AE Brendle, JS Fisher, EB Gherardini, DC Heins, JM Marsala, JM Raspberry, CC Santiago, JV Stephan, CL Saudek, CD Bradley, VL Brancati, FL Cappelli, S Charleston, JB Rubin, RR Stewart, KJ Sullivan, E Schade, DS Adams, KS Atler, LF Bowling, DA Boyle, PJ Burge, MR Canady, JL Chai, L Dorin, RI Facio, E Guillen, M Gutierrez, M Johannes, C Katz, P King, C McCalman, R Rassam, A Senter, W Waters, D Shamoon, H Brown, JO Cox, L Duffy, H Engel, S Friedler, A Howard-Century, CJ Longchamp, N Pompi, D Walker, EA Wylie-Rosett, J Zonszein, J Wing, RR Kramer, MK Barr, S Clifford, L Culyba, R Frazier, M Harris, L Harrier, S Henderson, W Jeffries, S Koenning, G Maholic, K Mullen, M Noel, A Orchard, T Smith, CF Smith, M Viteri, J Wilson, T Williams, KV Zgibor, J Arakaki, RF Latimer, RW Baker-Ladao, NK Beddow, RM Dias, LM Dupont, DA Fukuhara, LL Mau, MK Odom, SK Perry, RU Tokunaga, JS Knowler, WC Hoskin, MA Andre, VL Acton, KJ Antone, S Baptisto, NM Bennett, PH Bird, EC Dacawyma, TS Hanson, RL Jackson, MC Jay, PA Kobus, KM Roumain, J Rowse, DH Roy, RJ Yazzie, M Cooeyate, NJ Chavez, M Broussard, BA Ghahate, JM Hughte, G Ingraham, LE Kaskalla, RS Kessler, D Nashboo, Y Poirier, S Percy, CA Barber, R Benson, MB Duncan, R Glass, M Gohdes, D Grant, W Horse, E Morgan, T Reidy, M Bain, R Bambad, J Brenneman, T Dunegan, C Edelstein, SL Grimes, KL Jones, S Jones, TL Klepac, H Lachin, JM Mucik, P Orlosky, R Rochon, J Stimpson, CE Van Aerden, C Eastman, R Garfield, S Harris, M Andres, R Engelgau, M Narayan, V Williamson, D Herman, W Chandler, WL Marcovina, SM McMillan, T Rautaharju, PM Rautaharju, FSR Mayer-Davis, EJ O'Leary, DH Funk, LRC O'Leary, KA Scherzinger, AL Stamm, ER Gillis, BP Kriska, AM Huffmyer, C Meier, A Venditti, EM Wing, RR Haffner, SM Ratner, RE Olefsky, JM Santiago, JV Saudek, CD Knowler, WC Montez, MG Fujimoto, WY Hamman, RF Nathan, DM
Citation: Ga. Bray et al., The Diabetes Prevention Program - Design and methods for a clinical trial in the prevention of type 2 diabetes, DIABET CARE, 22(4), 1999, pp. 623-634
Epidemiological studies on the effects of hyperglycemia and improvement ofglycemic control on macrovascular events in type 2 diabetes
Authors: Haffner, SM
Citation: Sm. Haffner, Epidemiological studies on the effects of hyperglycemia and improvement ofglycemic control on macrovascular events in type 2 diabetes, DIABET CARE, 22, 1999, pp. C54-C56
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity - The insulin resistance atherosclerosis study
Authors: Festa, A D'Agostino, R Mykkanen, L Tracy, RP Hales, CN Howard, BV Haffner, SM
Citation: A. Festa et al., LDL particle size in relation to insulin, proinsulin, and insulin sensitivity - The insulin resistance atherosclerosis study, DIABET CARE, 22(10), 1999, pp. 1688-1693
Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The insulin resistance atherosclerosis study (IRAS)
Authors: Festa, A D'Agostino, R Rautaharju, P O'Leary, DH Rewers, M Mykkanen, L Haffner, SM
Citation: A. Festa et al., Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The insulin resistance atherosclerosis study (IRAS), STROKE, 30(8), 1999, pp. 1566-1571
Genetics of atherosclerosis risk factors in Mexican Americans
Authors: MacCluer, JW Stern, MP Almasy, L Atwood, LA Blangero, J Comuzzie, AG Dyke, B Haffner, SM Henkel, RD Hixson, JE Kammerer, CM Mahaney, MC Mitchell, BD Rainwater, DL Samollow, PB Sharp, RM VandeBerg, JL Williams, JT
Citation: Jw. Maccluer et al., Genetics of atherosclerosis risk factors in Mexican Americans, NUTR REV, 57(5), 1999, pp. S59-S65
Trp(64)Arg polymorphism of the beta(3)-adrenergic receptor gene in pregnancy: Association with mild gestational diabetes mellitus
Authors: Festa, A Krugluger, W Shnawa, N Hopmeier, P Haffner, SM Schernthaner, G
Citation: A. Festa et al., Trp(64)Arg polymorphism of the beta(3)-adrenergic receptor gene in pregnancy: Association with mild gestational diabetes mellitus, J CLIN END, 84(5), 1999, pp. 1695-1699
The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed Type II diabetes: the Insulin Resistance Atherosclerosis Study
Authors: Mykkanen, L Zaccaro, DJ Hales, CN Festa, A Haffner, SM
Citation: L. Mykkanen et al., The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed Type II diabetes: the Insulin Resistance Atherosclerosis Study, DIABETOLOG, 42(9), 1999, pp. 1060-1066
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels - Subgroup analyses in the Scandinavian simvastatin survival study
Authors: Haffner, SM Alexander, CM Cook, TJ Boccuzzi, SJ Musliner, TA Pedersen, TR Kjekshus, J Pyorala, K
Citation: Sm. Haffner et al., Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels - Subgroup analyses in the Scandinavian simvastatin survival study, ARCH IN MED, 159(22), 1999, pp. 2661-2667
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996 - Resultsfrom the San Antonio Heart Study
Authors: Burke, JP Williams, K Gaskill, SP Hazuda, HP Haffner, SM Stern, MP
Citation: Jp. Burke et al., Rapid rise in the incidence of type 2 diabetes from 1987 to 1996 - Resultsfrom the San Antonio Heart Study, ARCH IN MED, 159(13), 1999, pp. 1450-1456
Epidemiology of insulin resistance and its relation to coronary artery disease
Authors: Haffner, SM
Citation: Sm. Haffner, Epidemiology of insulin resistance and its relation to coronary artery disease, AM J CARD, 84(1A), 1999, pp. 11J-14J
A symposium: Clinical significance and management of hypertriglyceridemia - Introduction
Authors: Haffner, SM
Citation: Sm. Haffner, A symposium: Clinical significance and management of hypertriglyceridemia - Introduction, AM J CARD, 83(9B), 1999, pp. 1F-2F
Diabetes, hyperlipidemia, and coronary artery disease
Authors: Haffner, SM
Citation: Sm. Haffner, Diabetes, hyperlipidemia, and coronary artery disease, AM J CARD, 83(9B), 1999, pp. 17F-21F
Role of fibrates in the management of hypertriglyceridemia
Authors: Rader, DJ Haffner, SM
Citation: Dj. Rader et Sm. Haffner, Role of fibrates in the management of hypertriglyceridemia, AM J CARD, 83(9B), 1999, pp. 30F-35F
Risultati: 1-25 | 26-50 | 51-53